The Definitive Mold Resource  |  Learn more about mold and how to deal with it.

Mold Blindspots Series

Part 6: Aspergillosis, A Common Fungal Infection

November 9, 2023

Aspergillosis, A Common Fungal Infection

By Cesar Collado

Aspergillosis causes illness on a variety of levels.  First, it is an allergen triggering allergic responses. Second, it might colonize and simply reproduce in specific areas or cavities in the human body, especially sinuses and lungs leading to infection.  Third, Aspergillus is a pathogen and can cause a life-threatening infection and a dangerous immune response. Finally, it produces secondary metabolites called mycotoxins that are toxic and can cause organ failure and neurological problems.  An aspergillus infection can lead to the body quickly reaching its “Toxic Load” where a patient becomes sensitive to almost any chemical, biochemical, or smell.

Aspergillus is a fungi genus consisting of several hundred species found in various climates. Approximately 60 species are known be relevant pathogens resulting in various human illnesses.  You will find Aspergillus species almost everywhere in the environment, such as on plants, trees, soil, and decaying vegetation.  Aspergillus is commonly identified on moldy foods, especially starches such as bread. It is also a common indoor mold due to its proclivity to grow on drywall when exposed to moisture, commonly used in most residential and commercial settings.

Most people breathe in Aspergillus daily without getting sick.  However, people with a weakened immune system or respiratory diseases will be at higher risk of pathogenic aspergillosis.

Aspergillus Microscope Fungal Infections

Types of Aspergillus Fungal Infections:

Aspergillosis manifests in several different forms, each affecting different parts of the body:

  • Allergic Bronchopulmonary Aspergillosis (ABPA) causes inflammation in the lungs that will result in coughing and wheezing. ABPA most commonly impacts individuals with asthma or cystic fibrosis.
  • Chronic Pulmonary Aspergillosis (CPA) impacts people with pre-existing lung conditions, like chronic obstructive pulmonary disease (COPD) or tuberculosis. As a result, Invasive Pulmonary Aspergillosis (IPA), the most severe form, often affects immunocompromised patients, such as transplant recipients or individuals with HIV/AIDS.
  • Aspergillomas: A “fungal ball” of aspergillus that can reproduce and colonize in the lungs or sinuses. The fungi can cause inflammation, mucous production, and headaches.
  • Invasive Aspergillosis: A serious fungal infection can occur in in people with compromised immune systems such as organ or stem cell transplant patients.  The infection commonly affects the lungs but can spread to other parts of the body.
  • Mycotoxicosis: Several mycotoxins are secondary metabolites produced by Aspergillus species. The most potent toxins are aflatoxins, ochratoxins, gliotoxin, fumonisins, sterigmatocystin, and patulin. Mycotoxicosis occurs when either eaten or released by a fungal presence in the body. Severe symptoms can result from the following cellular activity:
    • Potent carcinogenic activity and acute toxicity to various human cells such as lymphocytes, monocytes, granulocytes, hepatocytes, renal cells, lung epithelial cells
    • Immuno-suppressive activities
    • Suppression of the function of macrophages
    • Direct access to the brain due to inhalation and penetration through the blood-brain barrier

Read more about the challenges of diagnosing mycotoxin poisoning in the Toxic Mold Mystery article.


X-Ray of Pulmonary Aspergillosis, Fungal Infections

X-Ray of Pulmonary Aspergillosis

Aspergillosis Infection

Systemic Aspergillosis Infection

Lung Aspergillosis

Aspergillosis in Lungs

Sinus Aspergillus

Aspergillosis in Sinuses

Aspergillosis Fungal Infection Symptoms and Risk Factors

The symptoms of aspergillosis will vary depending on the form of the infection. ABPA can cause wheezing, coughing, and increased mucus production, while CPA might lead to weight loss, fatigue, and persistent chest pain. IPA, being the most severe form, can result in fever, severe cough, and shortness of breath, and if left untreated, it can lead to a life-threatening condition. Common risk factors include use of immunosuppressive medications, chemotherapy, organ transplantation, and prolonged use of corticosteroids.

Fungal Infection Diagnostic Methods

Diagnosing aspergillosis involves a combination of clinical assessment, imaging studies, and laboratory tests. Chest X-rays or CT scans can help identify lung abnormalities associated with the infection. A sputum culture or bronchoscopy may be performed to collect respiratory samples for fungal identification. Blood tests can detect specific antibodies and antigens associated with Aspergillus. Accurate and timely diagnosis is crucial to ensure appropriate treatment.  Urine testing is available but is not approved by the FDA.  Unfortunately, urine testing is often inconclusive.

Fungal Infection Treatment Options

The treatment approach for aspergillosis depends on the type and severity of the infection, as well as the patient’s overall health. Antifungal medications, such as voriconazole and itraconazole, are commonly prescribed to combat the fungal growth. For ABPA, corticosteroids might be used to reduce inflammation and manage allergic responses. In severe cases of IPA, a combination of anti-fungal drugs and surgical intervention to remove infected tissue might be necessary.  Amphotericin B is the most potent anti-fungal that may be used in a hospital setting.  Extreme caution must be taken with its use due to hepatotoxicity.

Preventive Measures for Fungal Infection

Preventing aspergillosis involves taking precautions, especially for high-risk individuals. Hospital environments should maintain strict infection control measures to minimize the risk of fungal exposure. Individuals with weakened immune systems or lung conditions should avoid environments with high mold exposure and take prescribed medications as directed. Proper hygiene, such as washing hands frequently and washing clothing with an antimicrobial laundry detergent can also reduce the risk of fungal infections.


Aspergillosis is a serious fungal infection that affects individuals with compromised immune systems and underlying lung conditions. Understanding the different forms of the infection, recognizing the symptoms, and seeking early diagnosis are crucial steps in managing and treating aspergillosis effectively. With appropriate medical care and preventive measures, the impact of aspergillosis on public health can be minimized, and those at risk can be better protected.

Mold Blind Spots Series

This article series sheds light on often overlooked mold sensitivity triggers or mold blind spots. Look for our weekly published articles beginning mid-September 2023.

Mold Blind Spot 1:

The Superantigen Response to Mold

There are certain situations where mold induces a cytokine storm.  A cytokine storm is an intense inflammatory reaction that can lead to life-threatening conditions. The immune system goes into overdrive in producing inflammatory signals called cytokines.  This condition is difficult to diagnose and is often misdiagnosed in emergency settings.

Mold test Plates
Mold Blind Spot 2:

Microbial Coexistence

Most infectious conditions involve multiple microbial contaminations.  Single organism infections do occur in various environments. However, single fungal microorganism contamination is a rare phenomenon unless the specific mold has colonized and reproduced significantly in part of the human body.

Microbial soup
Mold Blind Spot 3:

What is Microbial Soup?

October 5, 2023

In most infection cases, biofilms are formed collaboratively by different microorganisms in order to mutually survive in the body. There are many common microbial combinations that are prevalent in water-damaged homes.

Hospital infections
Mold Blind Spot 4:

Hospital Acquired Infections

October 12, 2023

While hospitals would seem to be well maintained and regularly disinfected, many people develop infections after being in the hospital for a couple days.  The “nosocomial” infections are prevalent, often resistant, and can be life threatening.

Mold Blind Spot 5:

Vulnerable Populations

November 2, 2023

The presence of mold can pose significant health risks for immunocompromised individuals. Explore the unique health circumstances that impact a family’s well-being.

Mold test Plates
Mold Blind Spot 6:

Aspergillosis, A Common Fungal Infection

November 9, 2023

Aspergillus is the most common fungal infection that often involves hospitalizations. Aspergillosis infections involve significant reproduction and colonization inside the human body. Aspergillus is also a mycotoxin producing mold. It is helpful to understand fungal infections and the impact on health and potential treatment approaches.

Mold Blind Spot 7:

Candida Overgrowth

November 16, 2023

Candida albicans are single cell yeasts that are part of the fungi empire and also a component of the human microbiome. Candida overgrowth, often linked to diet and antibiotic usage, can have significant chronic and acute health implications.

Mold test Plates
Mold Blind Spot 8:

Understanding "The Body’s Toxic Load"

November 22, 2023

The human body is limited in it’s ability to process toxic substances like pollutants, heavy metals, and more. Learn how mold illness can result from single severe exposure, or cumulative minor ones, leading to severe mold sensitivity. The body’s “toxic load” is referenced when the body has reached its lifetime maximum of toxins and becomes hypersensitive to almost any allergen or toxin.